| Compound | Size | Market Low | Market Avg |
|---|
Vendor Assessment Methodology
All vendors in this dataset undergo a standardized assessment process. Scores are derived from verifiable criteria and aggregated community feedback. Assessment is updated quarterly.
Assessment Criteria
- GMP certification verification through regulatory database cross-reference and facility audit documentation
- Certificate of Analysis (COA) review including HPLC purity data, mass spectrometry identity confirmation, and batch consistency
- Third-party testing requirements: independent laboratory verification with published methodology
- Community feedback aggregation from forums, review platforms, and direct survey data (n=500+)
- Shipping and handling standards including cold-chain compliance, packaging integrity, and transit time consistency
Assessed Vendors
| Vendor | Location | cGMP | COA | 3rd-Party Testing | Rating | |
|---|---|---|---|---|---|---|
| LiveWell Peptides ★ Preferred | Dallas, TX | Yes | Yes | Yes | 4.9/5 | Visit → Official Sponsor Paid partnership |
| ★★ Core Peptides | Houston, TX | Yes | Yes | Yes | 4.5/5 | Visit → |
| ★★★ Limitless Life Nootropics | Phoenix, AZ | No | Yes | Yes | 4.6/5 | Visit → |
| ★★ Biotech Peptides | Nashville, TN | No | Yes | Yes | 4.4/5 | Visit → |
| ★★ Amino Asylum | Austin, TX | No | Yes | No | 4.3/5 | Visit → |
How Market Prices Are Determined
Pricing data is aggregated from 20+ research peptide vendors operating in the United States. The methodology is designed to produce reliable market reference points rather than promotional pricing.
- Data collected from vendor websites, verified distributors, and direct vendor communication on a weekly cadence
- Statistical outliers (prices more than 2 standard deviations from the mean) are excluded from averages
- Only vendors with verifiable COA documentation are included in the dataset
- Prices reflect standard retail quantities; bulk or wholesale pricing is excluded
- Market Low represents the 10th percentile; Market High represents the 90th percentile
- Historical price tracking enables trend analysis (available in quarterly reports)
This data is provided for educational and research reference purposes. Prices may vary based on order size, vendor promotions, and market conditions at time of purchase.
Frequently Asked Questions
Peptide prices vary based on manufacturing standards (GMP vs non-GMP facilities), purity levels (typically 95-99%+), third-party testing scope, raw material sourcing, and operational overhead. Facilities with GMP certification and independent COA verification generally operate at higher price points due to quality assurance costs. Sequence length and synthesis complexity also affect base production cost.
Purity is primarily determined by the synthesis method (solid-phase vs liquid-phase), purification technique (HPLC, ion exchange), and quality control testing. Higher purity (>98%) requires additional purification steps, increasing production cost. Longer-sequence peptides are also more expensive due to synthesis complexity and lower yields. The number of amino acids in the sequence has a roughly exponential relationship to synthesis difficulty.
A valid Certificate of Analysis should include: the laboratory name and accreditation, batch/lot number matching the product, HPLC chromatogram showing purity percentage, mass spectrometry data confirming molecular identity, endotoxin testing results, and a date within a reasonable timeframe. Cross-reference the testing laboratory independently to confirm legitimacy. Request the raw chromatogram data if only summary results are provided.
Good Manufacturing Practice (GMP) certification indicates a facility follows standardized production protocols that ensure consistent product quality. GMP-certified peptide facilities maintain controlled environments, documented procedures, equipment calibration records, and undergo regular third-party audits. This certification is issued by regulatory bodies and adds manufacturing cost but provides quality assurance for the end product.